Augmedix Announces an Updated Version of Its proprietary Notebuilder Tool

Notebuilder is the key natural language processing (NLP) component of the Augmedix technology platform, enabling virtual scribes to create best practice clinical notes powered by intelligent automation.

Augmedix notes the updated Notebuilder now includes all three major sections of the note (History of Present Illness, Physical Exam and Assessment & Plan), external medication datasets and customized note content based upon clinician preferences.

Notebuilder utilizes identifiers such as specialty, visit type, complaints, symptoms and frequency alongside scribe specific inputs, to automatically generate and organize clinically relevant structured medical notes which can then be inserted into the patient’s electronic health record (EHR). Selection options are dynamically filtered as the virtual scribe makes entries such that the most relevant selections are displayed. This intelligent automation approach achieves cost-effective, accurate, and timely documentation.

“We often hear how artificial intelligence (AI) will replace the human workforce. We have found that when it comes to capturing clinical conversations, which are essentially unstructured data, the most effective solution available today is the use of a hybrid model: blending both AI and human intellect,” said Manny Krakaris, Chief Executive Officer at Augmedix. “We are thrilled to bring our enhanced Notebuilder solution to our global scribe workforce. Based on the experience of our scribes already using the tool across the globe, we know that we are delivering cost-effective, timely and accurate clinical documentation to our customers.”

Notebuilder allows customizations based upon specialty, clinic or individual clinician preferences. Specific clinician preference templates can be saved within the tool and used by the virtual scribe as needed. Notebuilder provides virtual scribes with access to medical data sets such as a medication database with dosages, frequency and related side effects.

“Technology is built to help clinicians, but we know that it often has the opposite effect, slowing down processes and impairing operational efficiencies,” said Dr. Davin Lundquist, Chief Medical Officer at Augmedix. “Notebuilder empowers clinicians to care for their patients while the visit is simultaneously being documented in real-time by a specialty trained scribe. Notebuilder enables our clinicians to have natural, ambient conversations with their patients unlike other solutions which force more rigidity and behavior change, and in many cases, outright dictation. Technology is best when it enhances clinician workflow—we solve this challenge by combining AI and the knowledge of clinicians to more efficiently complete documentation.”

 

SourceAugmedix
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version